In a model of atherosclerosis in apoE−/− mice, HTyr administration (10 mg/kg/day orally, for 16 weeks) significantly reduced the extent of aorta atherosclerotic lesions as well as serum CRP, TNF-α, IL-1β and IL-6 levels, while it increased IL-10. Here, APOE is linked to atherosclerosis.